Characterization of the antiviral effects of REP 2139 on the HBV lifecycle in vitro
Richard Boulon, Matthieu Blanchet, Matthieu Lemasson, Andrew Vaillant, Patrick Labonté
Topics & Concepts
HBsAgHepatitis B virusVirologyBiologyImmune systemVirusAntibodyHBeAgImmunologyHepatitis B Virus StudiesHepatitis C virus researchViral Infections and Outbreaks Research